cagrilintide retatrutide 10mg + 2mg Cagrilintide vs Retatrutide Compared |

Six trials involving approximately 900 participants confirmed no treatment-related serious adverse events, no IGF-1 elevation, no cardiovascular events, and no immunogenic response

[DOI] [PubMed] [Google Scholar] 9.Sikiric P., Drmic D., Sever M., Klicek R., Blagaic A.B., Tvrdeic A., Kralj T., Kovac K.K., Vukojevic J., Siroglavic M., et al

If youre running a proper first-in-human safety trial with a characterized compound, defined dose, defined route, and outcomes that will be published, thats science

The fact that these substances have been nominated and are being reviewed does not mean they will be added to the 503A Bulks List

Always start low and watch response